###begin article-title 0
###xml 111 128 <span type="species:ncbi:10407">hepatitis B virus</span>
Association between the frequency of class II HLA antigens and the susceptibility to intrauterine infection of hepatitis B virus
###end article-title 0
###begin p 1
#These authors contributed equally to the work
###end p 1
###begin p 2
Conflict of interest: The authors have declared that no conflict of interest exists.
###end p 2
###begin p 3
###xml 1068 1070 1068 1070 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 62 79 <span type="species:ncbi:10407">hepatitis B virus</span>
###xml 81 84 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 123 126 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 138 141 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 152 155 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 259 266 <span type="species:ncbi:9606">infants</span>
###xml 429 432 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 479 486 <span type="species:ncbi:9606">infants</span>
###xml 530 537 <span type="species:ncbi:9606">infants</span>
###xml 701 707 <span type="species:ncbi:9606">infant</span>
###xml 1301 1308 <span type="species:ncbi:9606">infants</span>
###xml 1325 1328 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
Multiple factors determine the susceptibility to intrauterine hepatitis B virus (HBV) infection. These factors include the HBV structure, HBV mutation, HBV DNA level, placental barrier, the immune status of the mother, and the genetic make-ups of the newborn infants. Since HLA system is an integral component of the immune response, we hypothesized that the highly polymorphic HLA genes are the key determinants of intrauterine HBV infection. In this study, we selected newborn infants of HBsAg-positive mothers, and divided the infants into 2 groups: intrauterine infection group and non-intrauterine infection group according to the status whether or not they were infected at birth. Each infected infant was compared with 2 controls from the same birth cohort. HLA-DR allele typing was performed using a PCR-sequence specific primer (PCR-SSP) for 24 subjects with intrauterine infection and 48 controls without infection. We found that, among the fifteen (15) HLA-DR alleles assessed, HLA-DRB1*07 was the one, and the only one, significantly in excess (OR = 6.66, P = 0.004) in the intrauterine infection group compared to the non-intrauterine infection group. Our findings thus suggest that high frequency of HLA class II molecules, e.g. HLA-DRB1*07, is associated with the susceptibility of the infants to intrauterine HBV infection.
###end p 3
###begin title 4
1. Introduction
###end title 4
###begin p 5
###xml 322 323 322 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 769 772 769 772 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 803 804 803 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 806 807 806 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 809 810 809 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 1370 1371 1370 1371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 1373 1374 1373 1374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 1508 1509 1508 1509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 1511 1512 1511 1512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 1714 1715 1714 1715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 70 75 <span type="species:ncbi:9606">human</span>
###xml 163 180 <span type="species:ncbi:10407">hepatitis B virus</span>
###xml 182 185 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 271 277 <span type="species:ncbi:9606">people</span>
###xml 318 321 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 473 476 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 606 609 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 649 652 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 662 670 <span type="species:ncbi:9606">children</span>
###xml 743 746 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 783 789 <span type="species:ncbi:9606">infant</span>
###xml 965 970 <span type="species:ncbi:9606">women</span>
###xml 989 992 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 1018 1026 <span type="species:ncbi:9606">children</span>
###xml 1075 1078 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 1179 1182 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
Hepatitis B is a common disease worldwide. Approximately, one million human deaths in the world each year are attributable to the end stage sequelae of persistent hepatitis B virus (HBV) infection. The World Health Organization (WHO) has estimated that about 350 million people worldwide are chronically infected with HBV 1. These individuals are prone to the development of chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. In South East Asia, the mode of HBV infection is mainly vertical transmission in the perinatal period. In China, one of the major reasons for the high prevalence of HBV infection is that mothers transmit the HBV to their children during the intrauterine as well as perinatal periods. Approximately 50% HBV carriers got infected via mother-to-infant transmission 1, 2, 3. With the immunolization of hepatitis B vaccine and the use of hepatitis B immunoglobulin (HBIG) in hepatitis B surface antigen (HBsAg)-positive pregnant women, the incidence of HBV carrier status among the children has reduced dramatically. However, intrauterine HBV infection still occurs at high incidence. The exact mechanisms underlying intrauterine infection of HBV have not been completely elucidated. Previous studies showed that major histocompatibility complex (MHC) gene products were vital for the regulation of several antiviral immune reactions 4, 5. In addition, genetic factors controlling the host immune response could play an important role in determining the infection outcome 6, 7. These immune responses may be genetically determined, since studies on twins and families have suggested the contribution of an inherited component in the development of chronic hepatitis B infection 8.
###end p 5
###begin p 6
###xml 35 40 <span type="species:ncbi:9606">human</span>
###xml 277 282 <span type="species:ncbi:9606">human</span>
###xml 350 353 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
T cell responses are restricted by human leukocyte antigen (HLA) class I and class II molecules, which present antigens to CD8+ cytolytic T cells and CD4+ helper T cells, respectively. The genes encoding HLA class I and class II molecules are the most polymorphic genes in the human genome and are therefore ideal candidates for the investigation of HBV infection susceptibility.
###end p 6
###begin p 7
###xml 118 119 118 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 121 123 121 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 125 127 125 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 338 340 330 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 342 344 334 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 311 314 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 419 422 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
The association between HLA polymorphism and disease susceptibility as well as disease resistance has been documented 9, 10, 11. Recently, several non-genetic diseases were found to be related to gene polymorphism, and the relationship between the TNF-alpha -238 A and IFN-gamma +874 A alleles and intrauterine HBV infection was reported 12, 13. It is important to further examine the relationship between intrauterine HBV infection and HLA gene polymorphism.
###end p 7
###begin p 8
###xml 90 93 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 129 136 <span type="species:ncbi:9606">infants</span>
###xml 259 262 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 273 279 <span type="species:ncbi:9606">infant</span>
###xml 311 314 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 325 331 <span type="species:ncbi:9606">infant</span>
To study the association between the polymorphisms of HLA class II genes and intrauterine HBV infection, we selected the newborn infants delivered by HBsAg-positive mothers in this study and compared the frequencies of HLA phenotypes between the intrauterine HBV infection infant group and the non-intrauterine HBV infection infant group. To this end, an 1:2 matched nested case-control design was used.
###end p 8
###begin title 9
Materials and Methods
###end title 9
###begin title 10
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients
###end title 10
###begin p 11
###xml 24 32 <span type="species:ncbi:9606">patients</span>
###xml 110 115 <span type="species:ncbi:9606">Child</span>
###xml 231 243 <span type="species:ncbi:9606">participants</span>
###xml 288 296 <span type="species:ncbi:9606">patients</span>
###xml 319 326 <span type="species:ncbi:9606">infants</span>
###xml 406 409 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 462 469 <span type="species:ncbi:9606">infants</span>
###xml 531 534 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 566 573 <span type="species:ncbi:9606">patient</span>
###xml 680 685 <span type="species:ncbi:9606">women</span>
###xml 709 716 <span type="species:ncbi:9606">infants</span>
###xml 832 835 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
This study included the patients who visited the Department of Obstetrics and Gynecology at the Maternity and Child Care Centre of ShanXi Province from February 1999 to October 2004. A written consent was obtained from each of the participants. A nested case-control design was used. The patients selected were newborn infants whose blood were tested positive for HBsAg within 24 hr of birth (intrauterine HBV infection group, N = 24). The controls were newborn infants whose blood were tested negative for HBsAg (non-intrauterine HBV infection group, N = 48). Each patient was compared with 2 controls from the same cohort based on factors that were associated with the pregnant women as well as the newborn infants. These factors included age of the newborns (difference was within 6 months); same gender of the newborns, and the HBV marker levels in the maternal serum before delivery.
###end p 11
###begin title 12
Specimen Collection
###end title 12
###begin p 13
###xml 37 42 <span type="species:ncbi:9606">women</span>
###xml 91 98 <span type="species:ncbi:9606">infants</span>
###xml 225 232 <span type="species:ncbi:9606">infants</span>
Venous blood specimens from pregnant women and femoral vein blood specimens of the newborn infants were collected within 24 hr after birth and stored at -20degreesC for laboratory testing. After blood collection, the newborn infants immediately received hepatitis B immune globulin (HBIG) intramuscularly. They were also administered with hepatitis B vaccines at month 0, 1, and 6.
###end p 13
###begin title 14
###xml 26 29 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
Criteria for Intrauterine HBV Infection
###end title 14
###begin p 15
###xml 8 15 <span type="species:ncbi:9606">infants</span>
###xml 121 124 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 146 149 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 360 368 <span type="species:ncbi:9606">patients</span>
Newborn infants whose venous blood specimens were collected within 24 hr after birth, if found positive for HBsAg and/or HBV DNA, were considered HBV infected intrauterinely. In order to exclude the possibility that the intrauterine infection was tested positive due to transplacental maternal contamination of the fetal circulation, we followed up all of the patients for at least 6 months.
###end p 15
###begin title 16
Determination of HBsAg and HBeAg in Serum
###end title 16
###begin p 17
The presence of serum HBsAg and HBeAg was tested by ELISA (Shanghai Ke-hua Biotechnology Company, Shanghai, China). The results were generated using a Multiskan MK3 ELISA detector. A positive/negative (P/N) ratio >/= 2.1 was considered positive.
###end p 17
###begin title 18
Extraction of Genomic DNA
###end title 18
###begin p 19
The genomic DNA of the newborns was extracted from peripheral blood mononuclear cells by using the QIAamp blood kit (QIAGEN Inc., Chatsworth, CA) according to the manufacturer's instructions.
###end p 19
###begin title 20
HLA class II Typing
###end title 20
###begin p 21
HLA class II alleles were typed using the low-resolution DNA typing method--a polymerase chain reaction-sequence specific primer (PCR-SSP) technique (Pel-Freez, Brown Deer, WI) according to the manufacturer's instructions. Gene typing was performed using the software supplied by the company.
###end p 21
###begin title 22
Statistical analysis
###end title 22
###begin p 23
###xml 304 305 304 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 453 455 453 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
Statistical analysis was performed using the SPSS11.0 package software (SPSS Inc., Chicago, IL) on a computer. The frequency of HLA class II alleles was calculated by direct counting. Odds ratios (OR) reflect the likelihood of a specific allele being present in a subject who has intrauterine infection. P values were calculated by using conditional logistic regression. Statistic significance was tested by the chi-square test and Fisher's exact test. P < 0.05 was considered statistically significant.
###end p 23
###begin title 24
Results
###end title 24
###begin title 25
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
Patient characteristics
###end title 25
###begin p 26
###xml 469 470 467 468 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 470 471 468 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">=</italic>
###xml 478 480 476 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P&lt;</italic>
###xml 525 526 521 522 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 526 527 522 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">=</italic>
###xml 534 536 530 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P&lt;</italic>
###xml 761 762 757 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
###xml 856 857 852 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
###xml 39 44 <span type="species:ncbi:9606">women</span>
###xml 67 74 <span type="species:ncbi:9606">infants</span>
###xml 178 183 <span type="species:ncbi:9606">Child</span>
###xml 253 260 <span type="species:ncbi:9606">infants</span>
###xml 340 343 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 569 572 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 604 607 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 719 722 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
A total of 312 HBsAg-positive pregnant women delivered 313 newborn infants from February 1999 to October 2004 in the Department of Obstetrics and Gynecology at the Maternity and Child Care Centre of ShanXi Province. There were twins among these newborn infants. Among the 313 newborns, a total of 24 fulfilled our criteria for intrauterine HBV infection, and the infection rate was 7.7% (24/313). There was a significant difference in the maternal serum HBeAg rate (chi2=19.50, P<0.0001) and the newborn serum HBeAg rate (chi2=17.62, P<0.0001) between the intrauterine HBV infection and non-intrauterine HBV infection groups. These results indicate that maternal HBeAg-positive serum was a risk factor for intrauterine HBV infection, and the OR was 5.95 (Table 1). In addition, newborn HBeAg-positive serum was also a risk factor with an OR of 5.39 (Table 1).
###end p 26
###begin p 27
###xml 51 53 51 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 82 89 <span type="species:ncbi:9606">infants</span>
###xml 210 217 <span type="species:ncbi:9606">infants</span>
There was no statistically significant difference (P > 0.05) between the infected infants and controls with respect to the mean age and occupation of the mothers, nor the birth weight and gender of the newborn infants.
###end p 27
###begin title 28
Distribution of HLA-DR type in the intrauterine infection and non-intrauterine infection groups
###end title 28
###begin p 29
###xml 187 188 187 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">2</xref>
###xml 476 477 476 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">2</xref>
###xml 19 26 <span type="species:ncbi:9606">infants</span>
###xml 310 317 <span type="species:ncbi:9606">infants</span>
In all the newborn infants, DRB3* was the most frequent HLA-DR type. Its frequency was 37.5% in the intrauterine infection group and 29.17% in the non-intrauterine infection group (Table 2). In the intrauterine infection group, DRB1*07 and DRB3* were the most frequent HLA-DR type (both were 37.5%) in newborn infants, followed by DRB1*08 (20.83%). In the non-intrauterine infection group, DRB3* was the most frequent HLA-DR type (29.17%), followed by DRB1*12 (18.75%) (Table 2).
###end p 29
###begin title 30
Comparison of the frequency of the HLA-DR type between the intrauterine infection and non-intrauterine infection groups
###end title 30
###begin p 31
###xml 357 361 357 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P = </italic>
###xml 375 376 375 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">3</xref>
###xml 539 540 539 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">3</xref>
There was a significant difference in the distribution of HLA-DRB1*07 between the intrauterine infection and non-intrauterine infection groups. HLA-DRB1*07 was significantly more frequent in the intrauterine infection group (9 of 24 subjects, 37.5%) as compared to its frequency in the non-intrauterine infection group (4 of 48 subjects, 8.33%) (OR = 6.66, P = 0.004) (Table 3). The same analysis did not yield evidence supporting the significant (p<0.05) involvement of other HLA-DR types as determinants of intrauterine infection (Table 3).
###end p 31
###begin title 32
Discussion
###end title 32
###begin p 33
###xml 139 141 139 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 143 145 143 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 22 25 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 319 322 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 553 556 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 604 607 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 720 723 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 733 740 <span type="species:ncbi:9606">persons</span>
###xml 878 883 <span type="species:ncbi:9606">human</span>
###xml 966 969 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 1015 1020 <span type="species:ncbi:9606">human</span>
###xml 1373 1376 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 1413 1420 <span type="species:ncbi:9606">infants</span>
###xml 1474 1481 <span type="species:ncbi:9606">infants</span>
###xml 1568 1571 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 1615 1618 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
The susceptibility of HBV infection and the immune response to HBsAg-derived vaccines are determined by the genetic background of the host 14, 15. Other outcomes, including progression to cirrhosis and/or liver cancer, may also be influenced by host genetics. Thus far, the results of studies on host susceptibility to HBV infection are not conclusive. From the viewpoint of epidemiology, the major problem is the lack of appropriate subjects and suitable research design. In general, in order to conduct such studies, all subjects should be exposed to HBV. In addition, the time and mode of exposure to HBV should be comparable. Then, the difference in the distribution/frequencies of HLA types can be compared between HBV-infected persons and non-infected controls. Unfortunately, such study designs can hardly be realized if our epidemiological survey is based on the common human population. This is because: (1) It is difficult to determine the precise time of HBV exposure and to conduct follow-ups in common human population; (2) Theoretically, we would first require an isolated population from which our subjects can be selected. From this isolated population, the susceptible population should be screened, and subsequently, the infection status of this population should be followed up. However, this is extremely difficult to achieve. Fortunately, intrauterine HBV infection can be studied in newborn infants who are suitable study subjects. Because the newborn infants we studied were all delivered by HBsAg-positive mothers, they were all susceptible to HBV, and their mothers were the only source of HBV infection. These conditions well satisfies our research design requirements.
###end p 33
###begin p 34
###xml 273 274 273 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 276 278 276 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 280 282 280 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 284 286 284 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 425 427 425 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 429 431 429 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 38 41 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 329 332 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
HLA is involved in immune response to HBV. Although the relationship between various clinical manifestations and polymorphic HLA genes have been the subject of several studies, a definitive relationship has not yet been identified due to the inconsistencies of the results 4, 16, 17, 18. While the mechanism of susceptibility to HBV infection is not well clarified, it is known to be influenced by host immunogenetic factors 19, 20.
###end p 34
###begin p 35
###xml 356 358 356 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 360 362 360 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 120 123 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 203 206 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 238 245 <span type="species:ncbi:9606">infants</span>
###xml 394 397 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 586 589 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
Our results show that maternal HBeAg-positive serum and newborn HBeAg-positive serum were risk factors for intrauterine HBV infection. Several reports indicated that the likelihood of developing chronic HBV infection is higher in newborn infants, whose immune systems are thought to be immature, compared with the immunocompetent subjects during adulthood 14, 23. The natural course of chronic HBV infection can be divided into four phases based on the virus-host interaction: immune tolerance, immune clearance, low or non-replication, and reactivation. Most carries with intrauterine HBV infection are present in the immunotolerant phase. These carries are HBeAg positive but with normal alanine aminotransferase (ALT).
###end p 35
###begin p 36
###xml 459 461 459 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 850 851 850 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 853 855 853 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 74 77 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 112 118 <span type="species:ncbi:9606">people</span>
###xml 168 175 <span type="species:ncbi:9606">infants</span>
###xml 198 201 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 279 282 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 528 531 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 676 679 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 1288 1291 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
Our study has indicated that HLA-DRB1*07(HLA-DR7) type is associated with HBV intrauterine infection in Chinese people. It is noticeable that in this study the newborn infants with non-intrauterine HBV infection were selected as the controls, which ensured a similar exposure to HBV between the case and control groups. Our results imply that susceptibility to persistent infection is significantly associated with the presence of HLA-DR7 type. Almarri et al 21 failed to identify an association between HLA class I and chronic HBV infection. However, they discovered a significant decrease in the frequency of HLA-DR2 and an excess of HLA-DR7 in cases of chronic, persistent HBV infection. HLA-DRB1*1301/2 has been associated with viral clearance, but HLA-DRB1*07(HLA-DR7) is associated with non-responsiveness to vaccination with envelope proteins 4, 22. It is possible that high expression of HLA-DR7 on the cell surface may restrict the ability of helper T-lymphocytes to recognize HBsAg and B-cells and thereby result in persistent infection. Alternatively, HLA-DR7 may present viral peptides to a specific subset of CD4+ T cells and therefore alt the subsequent immune responses. Nevertheless, compared with our study, those studies did not show the role of HLA-DRB1*07(HLA-DR7) in HBV intrauterine infection.
###end p 36
###begin p 37
###xml 150 153 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 175 182 <span type="species:ncbi:9606">infants</span>
###xml 311 314 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 463 466 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 561 564 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 768 771 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 883 886 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 975 978 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
To the best of our knowledge, this is the first report involving the study on the association between HLA phenotypes and the outcomes of intrauterine HBV infection in newborn infants. Our data have showed that high frequency of specific HLA phenotypes, such as DRB1*07, is associated with the susceptibility to HBV intrauterine infection. Thus, our findings support the conclusion that genetic factors (e.g., HLA) are associated with the outcomes of intrauterine HBV infection. The characterization of functional significance of this particular HLA molecule in HBV intrauterine infection may provide insight to develop novel prophylactic and therapeutic approaches. Additional study is needed to validate these findings and to further explore the relationship between HBV intrauterine infection and the susceptible gene(s), as well as any other risk factors which may be involved in HBV intrauterine infection. Finally, investigation to elucidate the genetic pathogenesis of HBV intrauterine infection is among the future studies we plan to pursue.
###end p 37
###begin p 38
We thank Prof. De-Zhong Xu for his discussion. This work was supported by a grant from the National Natural Science Foundation of China (No. 30230320).
###end p 38
###begin article-title 39
Proceedings of the European Association for the Study of the Liver (EASL) International Consensus Conference on Hepatitis B, September 14-16, 2002, Geneva, Switzerland
###end article-title 39
###begin article-title 40
###xml 26 43 <span type="species:ncbi:10407">hepatitis B virus</span>
Perinatal transmission of hepatitis B virus and its prevention
###end article-title 40
###begin article-title 41
###xml 37 54 <span type="species:ncbi:10407">hepatitis B virus</span>
[Interruption of the transmission of hepatitis B virus from mother to babies]
###end article-title 41
###begin article-title 42
###xml 72 89 <span type="species:ncbi:10407">hepatitis B virus</span>
Comprehensive analysis of class I and class II HLA antigens and chronic hepatitis B virus infection
###end article-title 42
###begin article-title 43
###xml 68 83 <span type="species:ncbi:10090">transgenic mice</span>
###xml 98 104 <span type="species:ncbi:10090">murine</span>
###xml 130 145 <span type="species:ncbi:10090">transgenic mice</span>
###xml 168 174 <span type="species:ncbi:10090">murine</span>
Comparison of HLA-DR1-restricted T cell response induced in HLA-DR1 transgenic mice deficient for murine MHC class II and HLA-DR1 transgenic mice expressing endogenous murine MHC class II molecules
###end article-title 43
###begin article-title 44
###xml 68 71 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
Viral determinants and host immune responses in the pathogenesis of HBV infection
###end article-title 44
###begin article-title 45
###xml 18 35 <span type="species:ncbi:10407">hepatitis B virus</span>
Immune system and hepatitis B virus infection
###end article-title 45
###begin article-title 46
###xml 0 17 <span type="species:ncbi:10407">Hepatitis B virus</span>
Hepatitis B virus markers in Chinese twins
###end article-title 46
###begin article-title 47
###xml 31 48 <span type="species:ncbi:10407">hepatitis B virus</span>
HLA phenotypes and outcomes of hepatitis B virus infection in Taiwan
###end article-title 47
###begin article-title 48
###xml 53 70 <span type="species:ncbi:10407">hepatitis B virus</span>
Molecular analysis of HLA class II associations with hepatitis B virus clearance and vaccine nonresponsiveness
###end article-title 48
###begin article-title 49
###xml 16 21 <span type="species:ncbi:9606">human</span>
###xml 82 99 <span type="species:ncbi:10407">hepatitis B virus</span>
###xml 144 147 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 157 165 <span type="species:ncbi:9606">patients</span>
Relationship of human leukocyte antigen class II genes with the susceptibility to hepatitis B virus infection and the response to interferon in HBV-infected patients
###end article-title 49
###begin article-title 50
###xml 71 88 <span type="species:ncbi:10407">hepatitis B virus</span>
Relationship between cytokines gene polymorphism and susceptibility to hepatitis B virus intrauterine infection
###end article-title 50
###begin article-title 51
###xml 108 111 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
Relationship between genetic polymorphism of tumor necrosis factor-alpha and susceptibility to intrauterine HBV infection
###end article-title 51
###begin article-title 52
Easl international consensus conference on hepatitis B
###end article-title 52
###begin article-title 53
###xml 26 43 <span type="species:ncbi:10407">hepatitis B virus</span>
Perinatal transmission of hepatitis B virus and its prevention
###end article-title 53
###begin article-title 54
###xml 53 70 <span type="species:ncbi:10407">hepatitis B virus</span>
Influence of HLA classII molecules on the outcome of hepatitis B virus infection in population of Zhejiang Province in China
###end article-title 54
###begin article-title 55
Association between HLA class II gene and susceptibility or resistance to chronic hepatitis B
###end article-title 55
###begin article-title 56
###xml 20 37 <span type="species:ncbi:10407">hepatitis B virus</span>
Association between hepatitis B virus infection and HLA-DR type in Korea
###end article-title 56
###begin article-title 57
Host genetic factors influencing the outcome of hepatitis
###end article-title 57
###begin article-title 58
A vigorous virus-specific CD4+ T cell response may contribute to the association of HLA-DR13 with viral clearance in hepatitis B
###end article-title 58
###begin article-title 59
HLA and hepatitis B infection
###end article-title 59
###begin article-title 60
###xml 25 42 <span type="species:ncbi:10407">hepatitis B virus</span>
Vertical transmission of hepatitis B virus despite maternal lamivudine therapy
###end article-title 60
###begin article-title 61
Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors
###end article-title 61
###begin p 62
Relationship of serum HBeAg in mothers and newborns to intrauterine infection
###end p 62
###begin p 63
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*P &lt; </italic>
*P < 0.0001
###end p 63
###begin p 64
Frequencies of HLA-DR types in the intrauterine infection and non-intrauterine infection groups#
###end p 64
###begin p 65
#The allele carrier frequencies are referred to the frequencies of the population, not individuals.
###end p 65
###begin p 66
Comparison of HLA-DR types between the intrauterine infection and non-intrauterine infection groups
###end p 66

